(
 (((:EGFR 1) (:IDH1 -1)) 
  ((0.5 (:Bevacizumab)) (0.25 (:Bevacizumab :Cabazitaxel)) (0.25 (:Cabazitaxel :Disatinib :Nivolumab))))
 (((:IDH2 1)) 
  ((0.5 (:Temozolomide :TCAR)) (0.25 (:Cabazitaxel)) (0.25 (:Disatinib :Nivolumab))))
 (((:IDH2 1) (:HLA-A2 1) (:MGMT-PROMOTER 1))
  ((0.5 (:Cabazitaxel :Disatinib)) (0.3 (:Nivolumab)) (0.2 (:Bevacizumab))))
 )
